Posted by Michael Wonder on 21 Nov 2023
ICER to assess treatment for chronic obstructive pulmonary disease
21 November 2023 - Report will be subject of Midwest England CEPAC meeting in June 2024; draft scoping document open to public comment until 13 December 2023.
The ICER announced today that it will assess the comparative clinical effectiveness and value of ensifentrine for the treatment of chronic obstructive pulmonary disease.
